Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1984 May 15;220(1):207–212. doi: 10.1042/bj2200207

Phosphorylated adenosine derivatives as low-affinity adenosine-receptor agonists. Methodological implications for the adenylate cyclase assay.

W Schütz, G Steurer, E Tuisl, H Plass
PMCID: PMC1153611  PMID: 6331407

Abstract

In cellular systems provided with activatory (Ra-site) receptors for adenosine, such as rat cerebral microvessels and rat liver plasma membranes, the adenosine-receptor antagonist 8-phenyltheophylline (10 microM) significantly decreased adenylate cyclase activity if ATP was the substrate and only if GTP was present. With dATP as substrate, adenylate cyclase activities in both preparations remained unaffected by 8-phenyltheophylline. In rat cerebral-cortical membranes, with inhibitory (Ri-site) receptors for adenosine, 8-phenyltheophylline significantly enhanced adenylate cyclase activity only in the presence of GTP and if ATP was the substrate. In rat cardiac ventricular membranes, which are devoid of any adenylate cyclase-coupled adenosine receptor, the methylxanthine had no GTP-dependent effect, irrespective of the substrate used. All assay systems contained sufficiently high amounts of adenosine deaminase (2.5 units/ml), since no endogenous adenosine, formed from ATP, was found chromatographically. In order to demonstrate a direct influence of phosphorylated adenosine derivatives on adenylate cyclase activity, we investigated AMP in a dATP assay system. AMP was verified chromatographically to remain reasonably stable under the adenylate cyclase assay conditions. In the microvessels, AMP increased enzyme activity in the range 0.03-1.0 mM, an effect competitively antagonized by 8-phenyltheophylline. In the cortical membranes, 0.1 mM-AMP inhibited adenylate cyclase, which was partially reversed by the methylxanthine. The presence of GTP was again necessary for all observations. In the ventricular membranes, AMP had no effect. Since the efficacy of adenosine-receptor agonists and, probably, that of other hormones on adenylate cyclase activity can be more efficiently measured with dATP as the enzyme substrate, this nucleotide seems preferable for adenylate cyclase measurements in systems susceptible to modulation by adenosine.

Full text

PDF
207

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bruns R. F., Daly J. W., Snyder S. H. Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5547–5551. doi: 10.1073/pnas.77.9.5547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cooper D. M., Londos C. Evaluation of the effects of adenosine on hepatic and adipocyte adenylate cyclase under conditions where adenosine is not generated endogenously. J Cyclic Nucleotide Res. 1979;5(4):289–302. [PubMed] [Google Scholar]
  3. Cooper D. M., Londos C., Rodbell M. Adenosine receptor-mediated inhibition of rat cerebral cortical adenylate cyclase by a GTP-dependent process. Mol Pharmacol. 1980 Nov;18(3):598–601. [PubMed] [Google Scholar]
  4. Gentry M. K., Olsson R. A. A simple, specific, radioisotopic assay for 5'-nucleotidase. Anal Biochem. 1975 Apr;64(2):624–627. doi: 10.1016/0003-2697(75)90478-9. [DOI] [PubMed] [Google Scholar]
  5. Johnson R. A. Stimulatory and inhibitory effects of ATP-regenerating systems on liver adenylate cyclase. J Biol Chem. 1980 Sep 10;255(17):8252–8258. [PubMed] [Google Scholar]
  6. Londos C., Cooper D. M., Wolff J. Subclasses of external adenosine receptors. Proc Natl Acad Sci U S A. 1980 May;77(5):2551–2554. doi: 10.1073/pnas.77.5.2551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Schwabe U., Trost T. Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine. Naunyn Schmiedebergs Arch Pharmacol. 1980 Sep;313(3):179–187. doi: 10.1007/BF00505731. [DOI] [PubMed] [Google Scholar]
  8. Schütz W., Steurer G., Tuisl E. Functional identification of adenylate cyclase-coupled adenosine receptors in rat brain microvessels. Eur J Pharmacol. 1982 Nov 19;85(2):177–184. doi: 10.1016/0014-2999(82)90463-0. [DOI] [PubMed] [Google Scholar]
  9. Schütz W., Tuisl E. Evidence against adenylate cyclase-coupled adenosine receptors in the guinea pig heart. Eur J Pharmacol. 1981 Dec 3;76(2-3):285–288. doi: 10.1016/0014-2999(81)90516-1. [DOI] [PubMed] [Google Scholar]
  10. Schütz W., Tuisl E., Kraupp O. Adenosine receptor agonists: binding and adenylate cyclase stimulation in rat liver plasma membranes. Naunyn Schmiedebergs Arch Pharmacol. 1982 Apr;319(1):34–39. doi: 10.1007/BF00491475. [DOI] [PubMed] [Google Scholar]
  11. Shimizu H., Daly J. W., Creveling C. R. A radioisotopic method for measuring the formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain. J Neurochem. 1969 Dec;16(12):1609–1619. doi: 10.1111/j.1471-4159.1969.tb10360.x. [DOI] [PubMed] [Google Scholar]
  12. Taylor M. W., Hershey H. V., Levine R. A., Coy K., Olivelle S. Improved method of resolving nucleotides by reversed-phase high-performance liquid chromatography. J Chromatogr. 1981 Nov 27;219(1):133–139. doi: 10.1016/s0021-9673(00)80584-1. [DOI] [PubMed] [Google Scholar]
  13. Trost T., Schwabe U. Adenosine receptors in fat cells. Identification by (-)-N6-[3H]phenylisopropyladenosine binding. Mol Pharmacol. 1981 Mar;19(2):228–235. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES